Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CUCTSE:9158 +1.22%68 Return-on-Tangible-Equity is 41.39% as of Mar. 2026, which is 21% above its 10-year median of 34.22. GuruFocus rates TSE:9158 with a GF Score™ of 68/100 and a GF Value™ of 円2,352.83 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 586 Healthcare Providers & Services companies, CUC ranks better than 65.19% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. CUC's annualized net income for the quarter that ended in Mar. 2026 was 円5,684 Mil. CUC's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円13,733 Mil. Therefore, CUC's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 41.39%.
The historical rank and industry rank for CUC's Return-on-Tangible-Equity or its related term are showing as below:
TSE:9158'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 18.18 Med: 34.22 Max: 73.49
Current: 18.18
During the past 7 years, CUC's highest Return-on-Tangible-Equity was 73.49%. The lowest was 18.18%. And the median was 34.22%.
TSE:9158's Return-on-Tangible-Equity is ranked better than 65.19% of 586
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs TSE:9158: 18.18
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
CUC Return-on-Tangible-Equity Related Terms
CUC Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for CUC's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9158 vs HCA, THC, EHC: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, CUC's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CUC Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CUC's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where CUC's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 41.39% mean?
CUC (TSE:9158) has a Return-on-Tangible-Equity of 41.39% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CUC and its competitors. This is 21% above median its historical median of 34.22. Over the past decade, CUC's Return-on-Tangible-Equity has ranged from 18.18 to 73.49. According to the industry distribution chart, CUC ranks #204 out of 586 companies in the Healthcare Providers & Services industry, placing it in the top 34.8%.
Is CUC's Return-on-Tangible-Equity too high?
CUC's current Return-on-Tangible-Equity of 41.39% is 21% above median its 10-year median of 34.22. Over the past 10 years, this metric has ranged from a low of 18.18 to a high of 73.49. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.74. CUC's value of 41.39% is 285.4% above this industry median. Based on the distribution chart, CUC ranks #204 out of 586 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CUC has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CUC's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CUC ranks #204 out of 586 companies for Return-on-Tangible-Equity. This puts CUC in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.74. CUC's value of 41.39% is 285.4% above this benchmark. Historically, CUC's own Return-on-Tangible-Equity has ranged from 18.18 to 73.49 over the past decade. While the company's 10-year median is 34.22 vs. the industry median of 10.74, CUC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CUC's current Return-on-Tangible-Equity of 41.39% is 285.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CUC and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CUC's current Return-on-Tangible-Equity is 41.39%, which is 21% above median its own 10-year median of 34.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CUC stock overvalued right now?
Based on GuruFocus' analysis, CUC (TSE:9158) is currently considered Possible Value Trap. The stock's GF Value™ is 円2,352.83, compared to a current price of 円745.00 — trading 68.3% below its estimated fair value. The current Return-on-Tangible-Equity is 41.39%, which is 21% above median its 10-year median of 34.22 and 285.4% above the Healthcare Providers & Services industry median of 10.74. CUC's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For CUC (TSE:9158), the current Return-on-Tangible-Equity is 41.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CUC (TSE:9158) Overvalued in 2026?
Based on GuruFocus' analysis, CUC stock appears to be undervalued.
The current stock price of 円745.00 is trading 68.3% below its estimated GF Value™ of 円2,352.83.
GuruFocus considers CUC to be Possible Value Trap.
Key valuation signals for TSE:9158:
Return-on-Tangible-Equity: 41.39% (21% above median its 10-year median of 34.22)
GF Value™: 円2,352.83 vs. price of 円745.00 (68.3% below fair value)
Industry Position: 285.4% above the Healthcare Providers & Services median (#204 of 586)
No single metric tells the full story. See the TSE:9158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CUC Inc is engaged in Management support business for medical institutions, in-home nursing businesses, and hospice businesses. The company supports home-visit clinics where medical professionals visit the homes and facilities of patients who find it difficult to visit hospitals. It operates a home hospice specializing in caring for people with terminal cancer and intractable diseases and home-visit nursing and nursing care offices (visit only within the facility). We provide mental and physical support so users and their families can lead a positive treatment life.
68GF Score
Get the complete analysis for TSE:9158
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9158 has been successfully added to your 
